UBS Call 26 FRE 20.06.2025/ CH1302948554 /
1/9/2025 4:53:37 PM | Chg.+0.050 | Bid4:53:37 PM | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.940EUR | +5.62% | 0.940 Bid Size: 50,000 |
- Ask Size: - |
FRESENIUS SE+CO.KGAA... | 26.00 EUR | 6/20/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil